Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Liquidia Corp (LQDA)

Liquidia Corp (LQDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Liquidia Corp 419 DAVIS DRIVE SUITE 100 MORRISVILLE NC 27560 USA

www.liquidia.com Employees: 145 P: 919-328-4400 F: 919-328-4402

Description:

Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain which are in clinical stage. Liquidia Technologies, Inc. is based in NC, United States.

Key Statistics

Overview:

Market Capitalization, $K 939,471
Enterprise Value, $K 855,791
Shares Outstanding, K 84,637
Annual Sales, $ 17,490 K
Annual Net Income, $ -78,500 K
Last Quarter Sales, $ 4,450 K
Last Quarter Net Income, $ -23,160 K
EBIT, $ -111,630 K
EBITDA, $ -109,450 K
60-Month Beta 0.22
% of Insider Shareholders 30.10%
% of Institutional Shareholders 64.54%
Float, K 59,161
% Float 69.90%
Short Volume Ratio 0.62

Growth:

1-Year Return 3.74%
3-Year Return 137.69%
5-Year Return 124.70%
5-Year Revenue Growth 545.39%
5-Year Earnings Growth 83.89%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/13/24
Next Earnings Date N/A
Earnings Per Share ttm -1.70
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -54.17%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LQDA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -163.20%
Return-on-Assets % -67.15%
Profit Margin % -448.83%
Debt/Equity 0.00
Price/Sales 53.72
Price/Cash Flow N/A
Price/Book 8.11
Book Value/Share 1.31
Interest Coverage -11.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar